Literature DB >> 25436127

The localisation of cancer in the sigmoid, rectum or rectosigmoid junction using endoscopy or radiology-What is the most accurate method?

Ruud J L F Loffeld1, Marcel Flens1, Gerwin Fransen1, Frank C den Boer1, Aart van Bochove1.   

Abstract

INTRODUCTION: There is a difference in approach between colon and rectal cancer. AIM: EVALUATE THE METHODS OF LOCALISATION: endoscopy and radiology.
MATERIALS AND METHODS: Patients with cancer in the sigmoid or rectum diagnosed with endoscopy, were included. Patients underwent additional radiological examinations. The resection specimen served as the gold standard. A tumour surrounded by serosa was considered a sigmoid cancer, surrounded by perirectal fat, than it was rectal cancer. If the frontal edge of the tumour showed serosa and the dorsal plane perirectal fat than the tumour was located in the "rectosigmoid".
RESULTS: A total of 182 cancers were diagnosed. Of the 128 cancers with gold standard, endoscopy had the correct localisation in 112 (87.5%), and radiology in 114 (90.5%) cases. Concordance between both techniques was present in 80%. In 28 cases there was discordance. Radiology located 10 sigmoidal cancers wrongly in the rectum. One rectal cancer was placed in the sigmoid. In 16 cases the endoscopic localisation wrongly was the sigmoid. Sensitivity and specificity for endoscopy in sigmoidal cancer is 100% and 77% respectively, for rectal cancer 77% and 100%. Sensitivity of radiology for cancer in the sigmoid and rectum are 80% and 98% respectively. Specificity for both cancers is 98% and 80% respectively.
CONCLUSIONS: The endoscopist and the radiologist should not be too overconfident with localisation of the tumour in cases of high rectal or low sigmoidal cancer.

Entities:  

Keywords:  CT-scan staging; MRI staging; Rectal cancer; colonoscopy; endoscopy; localisation

Year:  2014        PMID: 25436127      PMCID: PMC4226835          DOI: 10.3978/j.issn.2078-6891.2014.087

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  12 in total

Review 1.  Colon cancer: comprehensive evaluation with 64-section CT colonography using water enema as intraluminal contrast agent-a pictorial review.

Authors:  Philippe Soyer; Lounis Hamzi; Marc Sirol; Florent Duchat; Xavier Dray; Lora Hristova; Vinciane Placé; Marc Pocard; Mourad Boudiaf
Journal:  Clin Imaging       Date:  2012 Mar-Apr       Impact factor: 1.605

2.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

3.  Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.

Authors:  Aimery de Gramont; Eric Van Cutsem; Hans-Joachim Schmoll; Josep Tabernero; Stephen Clarke; Malcolm J Moore; David Cunningham; Thomas H Cartwright; J Randolph Hecht; Fernando Rivera; Seock-Ah Im; György Bodoky; Ramon Salazar; Frédérique Maindrault-Goebel; Einat Shacham-Shmueli; Emilio Bajetta; Martina Makrutzki; Aijing Shang; Thierry André; Paulo M Hoff
Journal:  Lancet Oncol       Date:  2012-11-16       Impact factor: 41.316

4.  Perioperative tumor localization for laparoscopic colorectal surgery.

Authors:  S H Kim; J W Milsom; J M Church; K A Ludwig; A Garcia-Ruiz; J Okuda; V W Fazio
Journal:  Surg Endosc       Date:  1997-10       Impact factor: 4.584

5.  Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

Authors:  Daniel G Haller; Josep Tabernero; Jean Maroun; Filippo de Braud; Timothy Price; Eric Van Cutsem; Mark Hill; Frank Gilberg; Karen Rittweger; Hans-Joachim Schmoll
Journal:  J Clin Oncol       Date:  2011-03-07       Impact factor: 44.544

6.  Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.

Authors:  C Twelves; W Scheithauer; J McKendrick; J-F Seitz; G Van Hazel; A Wong; E Díaz-Rubio; F Gilberg; J Cassidy
Journal:  Ann Oncol       Date:  2011-09-06       Impact factor: 32.976

7.  Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.

Authors:  Sun Hee Rim; Laura Seeff; Faruque Ahmed; Jessica B King; Steven S Coughlin
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

8.  Comparison of CT colonography vs. conventional colonoscopy in mapping the segmental location of colon cancer before surgery.

Authors:  Emanuele Neri; Francesca Turini; Francesca Cerri; Lorenzo Faggioni; Paola Vagli; Gabriele Naldini; Carlo Bartolozzi
Journal:  Abdom Imaging       Date:  2009-09-18

9.  Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.

Authors:  Samuel Y Ngan; Bryan Burmeister; Richard J Fisher; Michael Solomon; David Goldstein; David Joseph; Stephen P Ackland; David Schache; Bev McClure; Sue-Anne McLachlan; Joseph McKendrick; Trevor Leong; Cris Hartopeanu; John Zalcberg; John Mackay
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

Review 10.  Neo-adjuvant radiotherapy in rectal cancer.

Authors:  Bengt Glimelius
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

View more
  6 in total

1.  Diagnostic utility of staging abdominal computerized tomography and repeat endoscopy in detecting localization errors at initial endoscopy in colorectal cancer.

Authors:  Arash Azin; Trevor Wood; Dhruvin Hirpara; Emily Le Souder; Sami A Chadi; Timothy Jackson; Allan Okrainec; Fayez A Quereshy
Journal:  Surg Endosc       Date:  2018-01-23       Impact factor: 4.584

2.  Preoperative Localization in Colonic Surgery (PLoCoS Study): a multicentric experience on behalf of the Italian Society of Colorectal Surgery (SICCR).

Authors:  Michele Manigrasso; Marco Milone; Mario Musella; Pietro Venetucci; Francesco Maione; Ugo Elmore; Gaetano Gallo; Roberto Perinotti; Giovanni Domenico De Palma
Journal:  Updates Surg       Date:  2021-10-05

3.  Adult and Elderly Risk Factors of Mortality in 23,614 Emergently Admitted Patients with Rectal or Rectosigmoid Junction Malignancy.

Authors:  Lior Levy; Abbas Smiley; Rifat Latifi
Journal:  Int J Environ Res Public Health       Date:  2022-07-27       Impact factor: 4.614

4.  Impact of Tumor Location on Survival in Patients With Colorectal Cancer: A Retrospective Cohort Study Based on Taiwan's Cancer Registry Database.

Authors:  Shou-Chun Yu; Kuang-Ming Liao; Chia-Lin Chou; Yu-Feng Tian; Jhi-Joung Wang; Chung-Han Ho; Yow-Ling Shiue
Journal:  Clin Med Insights Oncol       Date:  2022-07-19

5.  Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement.

Authors:  Erman Aytaç; Leyla Özer; Bilgi Baca; Emre Balık; Yersu Kapran; Orhun Cığ Taşkın; Başak Oyan Uluç; Mehmet Ufuk Abacıoğlu; Murat Gönenç; Yasemin Bölükbaşı; Barbaros E Çil; Bülent Baran; Cem Aygün; Mehmet Erdem Yıldız; Kemal Ünal; Burçak Erkol; Tunç Yaltı; Uğur Özbek; Tan Attila; Nurdan Tözün; Bengi Gürses; Sibel Erdamar; Özlem Er; Nuran Beşe; Orhan Bilge; Güralp Onur Ceyhan; Nil Molinas Mandel; Uğur Selek; Cengiz Yakıcıer; Hülya Kayserili Karabey; Murat Saruç; Volkan Özben; Eren Esen; Emre Özoran; Erkan Vardareli; Levent Güner; İsmail Hamzaoğlu; Dursun Buğra; Tayfun Karahasanoğlu; The İstanbul Group
Journal:  Turk J Gastroenterol       Date:  2022-08       Impact factor: 1.555

6.  Competing Endogenous RNA in Colorectal Cancer: An Analysis for Colon, Rectum, and Rectosigmoid Junction.

Authors:  Lucas Maciel Vieira; Natasha Andressa Nogueira Jorge; João Batista de Sousa; João Carlos Setubal; Peter F Stadler; Maria Emília Machado Telles Walter
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.